Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,258,729
+$113,810 QoQ
Shares Held
3,476
+6.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,539
of 3,140 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. AMGN ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
This page
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,258,729 | 3,476 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,144,919 | 3,254 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,066,375 | 3,258 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $987,135 | 3,498 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,050,388 | 3,762 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,755,584 | 5,635 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,343,338 | 5,154 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,649,392 | 5,119 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,405,712 | 4,499 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,275,459 | 4,486 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,532,842 | 5,322 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,165,074 | 4,335 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $664,949 | 2,995 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $751,600 | 3,109 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $790,021 | 3,008 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $620,977 | 2,755 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $680,510 | 2,797 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $626,797 | 2,592 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $377,724 | 1,679 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $482,715 | 2,270 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $449,231 | 1,843 | Shares | Sole | 2023-12-13 | |
| 2020-06-30 | $202,132 | 857 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||